[Discovery and development of a novel immunosuppressant, tacrolimus hydrate].

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

• Publication date

  1997-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1248/YAKUSHI1947.117.8_542PMID 9306728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tacrolimus ointment for atopic dermatitis.

  1994cited by this paper
• A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.

  1994cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

  1989cited by this paper
• Liver transplantation (2).

  1989cited by this paper
• Liver transplantation (1).

  1989cited by this paper
• FK 506 for liver, kidney, and pancreas transplantation.

  1989cited by this paper
• Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.

  1987cited by this paper
• Orthotopic liver transplantation in dogs receiving FK-506.

  1987cited by this paper
• Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.

  1987cited by this paper
• FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

  1987cited by this paper
• Effect of FK-506 on human mixed lymphocyte reaction in vitro.

  1987cited by this paper
• FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

  1987cited by this paper
• Selective in vitro growth of T lymphocytes from normal human bone marrows.

  1976cited by this paper

• Beyond Immunosuppression: The Intricate Relationship Between Tacrolimus and Microangiopathy

  2023cites this paper
• Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements?

  2023cites this paper
• PeruNPDB: the Peruvian Natural Products Database for in silico drug screening

  2023cites this paper
• Use of Topical Cyclosporin and Tacrolimus for Recurrent Subepithelial Infiltrates after Epidemic Keratoconjunctivitis

  2022cites this paper
• From drug discovery to coronaviruses: why restoring natural habitats is good for human health

  2021cites this paper
• Immunomodulatory Therapies for Interstitial Cystitis/Bladder Pain Syndrome

  2020cites this paper
• Editorial Comment from Dr Hanno to Intravesical tacrolimus in treatment of intractable bladder pain syndrome/interstitial cystitis‐a pilot study

  2019cites this paper
• Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome – A pilot study

  2019cites this paper
• Editorial Comment from Dr Homma to Intravesical tacrolimus in treatment of intractable bladder pain syndrome/interstitial cystitis‐a pilot study

  2019cites this paper
• Tacrolimus (Prograf)

  2019cites this paper
• Pharmacological management of interstitial cystitis /bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play

  2018cites this paper
• Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury.

  2017cites this paper
• Reutilization of Tacrolimus Extracted from Expired Prograf® Capsules: Physical, Chemical, and Pharmacological Assessment

  2015cites this paper
• The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome/interstitial cystitis.

  2012cites this paper
• Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation

  2012cites this paper
• [Drug development from natural fermentation products: establishing a manufacturing process which maximizes the potential of microorganisms].

  2010cites this paper
• The Literature of Heterocyclic Chemistry, Part VII: 1997–1999

  2001cites this paper
• Intragraft expression of p38 and activated p38 MARK (mitogen‐activated protein kinase) in rat small bowel transplantation

  2001cites this paper
• Intragraft expression of p38 and activated p38 MAPK (mitogen-activated protein kinase) in rat small bowel transplantation

  2001cites this paper
• Drug discovery: a historical perspective.

  2000cites this paper
• Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus.

  1999cites this paper
• Discovery and Development of a Novel Immunosuppressant, Tacrolimus Hydrate

  1998cites this paper